MTMR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.890800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.898400E-01
Normal-vs-Stage2
2.989800E-01
Normal-vs-Stage3
1.835190E-01
Normal-vs-Stage4
3.349000E-01
Stage1-vs-Stage2
7.559000E-01
Stage1-vs-Stage3
2.102100E-02
Stage1-vs-Stage4
2.551200E-01
Stage2-vs-Stage3
1.002190E-01
Stage2-vs-Stage4
3.370800E-01
Stage3-vs-Stage4
5.535700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.831000E-01
Normal-vs-AfricanAmerican
1.172800E-01
Normal-vs-Asian
1.866800E-01
Caucasian-vs-AfricanAmerican
8.268000E-01
Caucasian-vs-Asian
4.951000E-01
AfricanAmerican-vs-Asian
7.222600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.714600E-01
Normal-vs-Female
3.147800E-01
Male-vs-Female
1.252230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.588000E-01
Normal-vs-Age(41-60Yrs)
3.717800E-01
Normal-vs-Age(61-80Yrs)
2.610800E-01
Normal-vs-Age(81-100Yrs)
2.329400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.283200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.757600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.799700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.097610E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.861190E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.759200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.247800E-02
Normal-vs-Daily Drinker
2.445800E-01
Normal-vs-Weekly Drinker
2.519200E-01
Normal-vs-Occasional Drinker
3.624600E-01
Normal-vs-Social Drinker
6.343900E-02
Non Drinker-vs-Daily Drinker
3.229800E-01
Non Drinker-vs-Weekly Drinker
4.633200E-01
Non Drinker-vs-Occasional Drinker
3.929000E-01
Non Drinker-vs-Social Drinker
6.135200E-01
Daily Drinker-vs-Weekly Drinker
9.062400E-01
Daily Drinker-vs-Occasional Drinker
3.304300E-02
Daily Drinker-vs-Social Drinker
1.243160E-01
Weekly Drinker-vs-Occasional Drinker
7.399800E-02
Weekly Drinker-vs-Social Drinker
2.120600E-01
Occasional Drinker-vs-Social Drinker
7.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.940200E-01
Normal-vs-Grade 2
8.775800E-02
Normal-vs-Grade 3
6.773800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.619000E-01
Grade 1-vs-Grade 3
3.031600E-02
Grade 1-vs-Grade 4
2.940200E-01
Grade 2-vs-Grade 3
5.471800E-02
Grade 2-vs-Grade 4
8.775800E-02
Grade 3-vs-Grade 4
6.773800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.458200E-01
Normal-vs-NonDiabetic
2.942600E-01
Diabetic-vs-NonDiabetic
1.000380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.008200E-01
Normal-vs-NoPancreatitis
2.762200E-01
Pancreatitis-vs-NoPancreatitis
4.826600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.359780E-02
Normal-vs-N1
2.880400E-01
N0-vs-N1
9.077000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.631600E-01
Normal-vs-TP53-NonMutant
3.218400E-01
TP53-Mutant-vs-TP53-NonMutant
3.786200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
